Copyright Reports & Markets. All rights reserved.

Global HAE Treatments Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global HAE Treatments Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 C1 Esterase Inhibitors
    • 1.3.3 Kallikrein Inhibitors
    • 1.3.4 Bradykinin Receptor Antagonist
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global HAE Treatments Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Pharmacy
    • 1.4.4 Other
  • 1.5 Global HAE Treatments Market Size & Forecast
    • 1.5.1 Global HAE Treatments Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global HAE Treatments Sales Quantity (2021-2032)
    • 1.5.3 Global HAE Treatments Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Takeda Pharmaceuticals
    • 2.1.1 Takeda Pharmaceuticals Details
    • 2.1.2 Takeda Pharmaceuticals Major Business
    • 2.1.3 Takeda Pharmaceuticals HAE Treatments Product and Services
    • 2.1.4 Takeda Pharmaceuticals HAE Treatments Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Takeda Pharmaceuticals Recent Developments/Updates
  • 2.2 BioCryst Pharmaceuticals
    • 2.2.1 BioCryst Pharmaceuticals Details
    • 2.2.2 BioCryst Pharmaceuticals Major Business
    • 2.2.3 BioCryst Pharmaceuticals HAE Treatments Product and Services
    • 2.2.4 BioCryst Pharmaceuticals HAE Treatments Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 BioCryst Pharmaceuticals Recent Developments/Updates
  • 2.3 CSL Behring
    • 2.3.1 CSL Behring Details
    • 2.3.2 CSL Behring Major Business
    • 2.3.3 CSL Behring HAE Treatments Product and Services
    • 2.3.4 CSL Behring HAE Treatments Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 CSL Behring Recent Developments/Updates
  • 2.4 Pharming Healthcare
    • 2.4.1 Pharming Healthcare Details
    • 2.4.2 Pharming Healthcare Major Business
    • 2.4.3 Pharming Healthcare HAE Treatments Product and Services
    • 2.4.4 Pharming Healthcare HAE Treatments Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Pharming Healthcare Recent Developments/Updates

3 Competitive Environment: HAE Treatments by Manufacturer

  • 3.1 Global HAE Treatments Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global HAE Treatments Revenue by Manufacturer (2021-2026)
  • 3.3 Global HAE Treatments Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of HAE Treatments by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 HAE Treatments Manufacturer Market Share in 2025
    • 3.4.3 Top 6 HAE Treatments Manufacturer Market Share in 2025
  • 3.5 HAE Treatments Market: Overall Company Footprint Analysis
    • 3.5.1 HAE Treatments Market: Region Footprint
    • 3.5.2 HAE Treatments Market: Company Product Type Footprint
    • 3.5.3 HAE Treatments Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global HAE Treatments Market Size by Region
    • 4.1.1 Global HAE Treatments Sales Quantity by Region (2021-2032)
    • 4.1.2 Global HAE Treatments Consumption Value by Region (2021-2032)
    • 4.1.3 Global HAE Treatments Average Price by Region (2021-2032)
  • 4.2 North America HAE Treatments Consumption Value (2021-2032)
  • 4.3 Europe HAE Treatments Consumption Value (2021-2032)
  • 4.4 Asia-Pacific HAE Treatments Consumption Value (2021-2032)
  • 4.5 South America HAE Treatments Consumption Value (2021-2032)
  • 4.6 Middle East & Africa HAE Treatments Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global HAE Treatments Sales Quantity by Type (2021-2032)
  • 5.2 Global HAE Treatments Consumption Value by Type (2021-2032)
  • 5.3 Global HAE Treatments Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global HAE Treatments Sales Quantity by Application (2021-2032)
  • 6.2 Global HAE Treatments Consumption Value by Application (2021-2032)
  • 6.3 Global HAE Treatments Average Price by Application (2021-2032)

7 North America

  • 7.1 North America HAE Treatments Sales Quantity by Type (2021-2032)
  • 7.2 North America HAE Treatments Sales Quantity by Application (2021-2032)
  • 7.3 North America HAE Treatments Market Size by Country
    • 7.3.1 North America HAE Treatments Sales Quantity by Country (2021-2032)
    • 7.3.2 North America HAE Treatments Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe HAE Treatments Sales Quantity by Type (2021-2032)
  • 8.2 Europe HAE Treatments Sales Quantity by Application (2021-2032)
  • 8.3 Europe HAE Treatments Market Size by Country
    • 8.3.1 Europe HAE Treatments Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe HAE Treatments Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific HAE Treatments Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific HAE Treatments Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific HAE Treatments Market Size by Region
    • 9.3.1 Asia-Pacific HAE Treatments Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific HAE Treatments Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America HAE Treatments Sales Quantity by Type (2021-2032)
  • 10.2 South America HAE Treatments Sales Quantity by Application (2021-2032)
  • 10.3 South America HAE Treatments Market Size by Country
    • 10.3.1 South America HAE Treatments Sales Quantity by Country (2021-2032)
    • 10.3.2 South America HAE Treatments Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa HAE Treatments Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa HAE Treatments Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa HAE Treatments Market Size by Country
    • 11.3.1 Middle East & Africa HAE Treatments Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa HAE Treatments Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 HAE Treatments Market Drivers
  • 12.2 HAE Treatments Market Restraints
  • 12.3 HAE Treatments Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of HAE Treatments and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of HAE Treatments
  • 13.3 HAE Treatments Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 HAE Treatments Typical Distributors
  • 14.3 HAE Treatments Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global HAE Treatments market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    HAE (Hereditary Angioedema) treatments aim to manage and prevent the unpredictable and potentially life-threatening swelling episodes associated with the condition. These treatments target the underlying cause: a deficiency or dysfunction of C1 esterase inhibitor (C1-INH), which leads to uncontrolled activation of the complement and kallikrein-kinin systems, resulting in swelling. There are three main categories of HAE treatments: C1-INH replacement therapies (e.g., Berinert, Haegarda) that restore functional C1-INH levels; kallikrein inhibitors (e.g., Ecallantide) that block the enzyme responsible for bradykinin production; and bradykinin B2 receptor antagonists (e.g., Icatibant) that prevent bradykinin from causing vascular permeability and swelling.
    This report is a detailed and comprehensive analysis for global HAE Treatments market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global HAE Treatments market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global HAE Treatments market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global HAE Treatments market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global HAE Treatments market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for HAE Treatments
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global HAE Treatments market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    HAE Treatments market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    C1 Esterase Inhibitors
    Kallikrein Inhibitors
    Bradykinin Receptor Antagonist
    Market segment by Application
    Hospital and Clinic
    Pharmacy
    Other
    Major players covered
    Takeda Pharmaceuticals
    BioCryst Pharmaceuticals
    CSL Behring
    Pharming Healthcare
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe HAE Treatments product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of HAE Treatments, with price, sales quantity, revenue, and global market share of HAE Treatments from 2021 to 2026.
    Chapter 3, the HAE Treatments competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the HAE Treatments breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and HAE Treatments market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of HAE Treatments.
    Chapter 14 and 15, to describe HAE Treatments sales channel, distributors, customers, research findings and conclusion.

    Buy now